Both in Pharmaceuticals
CervoMed vs Edesa Biotech
Over the past year CRVO returned −74.6% and EDSA returned +30.4%; their daily moves had a correlation of 0.10.
CRVO −74.6% EDSA +30.4%Growth of $1, one year, split-adjusted
| Metric | CRVO | EDSA |
|---|---|---|
| Price | $1.75 | $2.70 |
| Market cap | $26.5M | $26.0M |
| Today | −20.81% | +5.47% |
| 1 month | −41.1% | −35.9% |
| 6 months | −52.6% | −85.2% |
| Year to date | −77.8% | +90.1% |
| 1 year | −74.0% | +25.0% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 79.9× | — |
| Net cash | $24.9M | $10.3M |
| Dividend yield | — | — |
| Volatility (60d) | 88.5% | 88.8% |
| Short % of float | 12.7% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).